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Using a de novo peptide inhibitor, Corza6 (C6), we demonstrate
that the human voltage-gated proton channel (hHv1) is the main
pathway for H+ efflux that allows capacitation in sperm and per-
mits sustained reactive oxygen species (ROS) production in white
blood cells (WBCs). C6 was identified by a phage-display strategy
whereby ∼1 million novel peptides were fabricated on an inhibitor
cysteine knot (ICK) scaffold and sorting on purified hHv1 protein.
Two C6 peptides bind to each dimeric channel, one on the S3–S4
loop of each voltage sensor domain (VSD). Binding is cooperative
with an equilibrium affinity (Kd) of ∼1 nM at −50 mV. As expected
for a VSD-directed toxin, C6 inhibits by shifting hHv1 activation to
more positive voltages, slowing opening and speeding closure, ef-
fects that diminish with membrane depolarization.
proton channel | C6 | ICK | venom | TIRF
The human voltage-gated proton channel (hHv1) is thought toplay critical roles as a H+ proton efflux pathway in both
normal biology and the pathogenesis of common disorders based
on its biophysical characterization and the effects of its knockout
in transgenic mice (1–3). hHv1 channels are formed by two
identical subunits each with four transmembrane spans (TMs)
that resemble the voltage sensor domains (VSDs) in other
voltage-gated ion channels (VGICs) and lack the two additional
TMs that contribute to forming the ion conduction pores in
those channels (4, 5). Unlike other VGICs, hHv1 has a H+-
selective conduction pathway within the VSD of each subunit
(6, 7). Studying the operation of the channel has been impeded
since known inhibitors are indiscriminate and weak suppressors
(8–10).
Inhibitor cysteine knot (ICK) peptides in the venoms of spi-
ders, scorpions, and snails are rich in VSD-directed toxins that
modify channel gating (that is, opening and closing) (11–13).
Recognized by a protein fold stabilized by three disulfide bonds,
most ICK toxins inhibit by binding to extracellular sites on
VGICs “trapping” the VSDs so they are unable to move nor-
mally in response to changes in transmembrane voltage (14, 15).
In the past, we designed phage-display libraries based on toxin
peptide scaffolds that target the ion conduction pores in potas-
sium channels to identify a high-affinity blocker with greater
specificity for the Kv1.3 voltage-gated channel (16) and for
KcsA, a channel that had no known regulator (17). Here, we
describe the development and use of Corza6 (C6), a high-
affinity, specific inhibitor of hHv1, to demonstrate the roles of
hHv1 in native human sperm and white blood cells (WBCs)
proposed by others (18–21). Seeking to harness VSD-directed
inhibitory mechanism to regulate hHv1, we constructed a
phage-display library of 1,047,280 variants based on the ICK
scaffold and sorted on purified hHv1 protein. C6 was identified
and characterized as a potent and specific inhibitor of hHv1
using electrophysiology and single-molecule total internal
reflection fluorescent microscopy (smTIRF). C6 binds to the
loop between the third and fourth membrane spans in the channel
(S3–S4 loop), a segment that confers inhibition to a C6-insensitive
proton channel [Ciona intestinalis Hv1 (CiHv1)] when transplanted
from hHv1.
C6 was used to evaluate two examples where the lack of a
selective hHv1 inhibitor had impeded confirmation of the role of
Hv1 in humans. Lishko et al. (18, 22) argue convincingly that
hHv1 is required for capacitation and the subsequent acrosomal
reaction in human sperm cells but comment on the need for a
specific inhibitor to validate their hypotheses because available
reagents were nonspecific and mouse sperm do not require
mHv1 for fertility (18, 20, 23). Several groups (20, 21, 23, 24) have
proposed that Hv1 is required to achieve sustained reactive oxygen
species (ROS) production in human phagocytic WBCs based on
the substantial reduction of the response in mHv1−/− mice during
respiratory burst, while recognizing that compensatory changes in
transgenic animals leave open alternative mechanisms in mice and
the possibility for different pathways in humans, as observed in
Significance
Some peptide toxins act by stabilizing the voltage sensor do-
mains (VSDs) of voltage-gated channels in open or closed
conformations. hHv1 is a human voltage-gated proton channel
and has lacked a specific inhibitor to assess its roles in physi-
ology. We designed a phage-display library of 1 million novel
peptides sharing an inhibitor cysteine knot (ICK) scaffold by
combining elements of natural toxins; phagemids expressing
Corza6 (C6) were selected by their capacity to bind to hHv1
protein. Two C6 peptides bind to the two VSDs in hHv1 and
thereby inhibit channel operation. C6 was employed to confirm
hypothesized roles for hHv1 in human sperm and white blood
cells. The method should prove amenable to designer toxin
identification for other voltage-gated channels.
Author contributions: R.Z., K.K., E.P., L.S.M., A.D., and S.A.N.G. designed research; R.Z.,
K.K., G.A.D.B., G.O., M.A.P., R.J.A., J.L.d.l.V.-B., Q.L., H.D., and S.A.N.G. performed re-
search; and R.Z., K.K., E.P., L.S.M., A.D., and S.A.N.G. wrote the paper.
Conflict of interest statement: Based in part on this work, a patent application (“HV1
Modulators and Uses,” PCT/US2017/068896) has been filed.
This article is a PNAS Direct Submission.
Published under the PNAS license.
1R.Z. and K.K. contributed equally to this work.
2To whom correspondence should be addressed. Email: sgoldstein3@luc.edu.
This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.
1073/pnas.1816189115/-/DCSupplemental.
Published online November 26, 2018.
www.pnas.org/cgi/doi/10.1073/pnas.1816189115 PNAS | vol. 115 | no. 50 | E11847–E11856
PH
YS
IO
LO
G
Y
sperm. Here, we settle the role of hHv1 in both human sperm
capacitation, and phorbol myristate acetate (PMA)-activated ROS
production in human WBCs, by studying the action of C6 on the
channels in these native environments.
Results
An ICK Scaffold Library with over 1 Million Variants. The spider toxin
ProTx-II (25) was chosen as the template for the design of the
phage library based on its potent ability to impede the movement
of voltage sensors in many VGICs. ProTx-II has 30 residues in-
cluding six cysteines that form three disulfide bonds (CysI to
CysIV, CysII to CysV, and CysIII to CysVI) to create and sta-
bilize the ICK backbone (Fig. 1A) (26). To preserve the ICK
architecture in designed toxins, the genes for 110 known and
predicted toxins that appeared to employ the same arrangement
of disulfide bonds were chosen from the sequences identified in a
BLAST search using the protein sequence of ProTx-II as bait (SI
Appendix, Table S1). The 110 protein sequences were aligned
based on the six structural cysteines, and CysII and CysV were
selected as the boundaries to define three domains, A, B, and C
(Fig. 1A). Oligonucleotides were designed to encode for each of
the unique domains in the 110 sequences yielding 95 A, 104 B,
and 106 C domains. Unidirectional ligation allowed restricted
permutations and recombination only in the correct order (A–B–C);
this maintained the relative positions of the cysteines in the primary
sequences and created a calculated diversity of 1,047,170 novel
peptides as well as reproducing the 110 template sequences. The
nucleotides for the peptides were ligated in-frame with phage coat
protein pIII to expose the encoded peptides on the phage surface,
as before in the pore-directed toxin scaffold libraries (16, 17).
Library Sorting on Purified hHv1 Isolates C6. A variant of
hHv1 lacking portions of the N and C termini (hHv1-VSD) was
purified and biotinylated as described before (27). The bio-
tinylated hHv1 protein was immobilized on streptavidin-coupled
magnetic beads or adhered directly in plastic wells in sequential
panning rounds as the target for phage sorting as described in
Materials and Methods. During each panning round, phages were
incubated with immobilized hHv1 protein, poorly associated
phages were separated from those more stably bound by wash-
ing, and then the bound phages were eluted and amplified for
the next sorting step. After five rounds, phage enrichment was
observed with hHv1 protein compared with control wells (Fig.
1A) and DNA sequencing of 48 clones identified the novel
peptide C6 (Fig. 1B) that had been enriched out of the ∼1 mil-
lion predicted variants. Of the enriched phagemids, 6.25%
expressed C6, indicating an increase of ∼65,000-fold from its
starting abundance. Supporting specific binding, phages expressing
C6 were shown by ELISA to bind to immobilized hHv1 proteins
in a stable and specific manner, whereas recovery was negligible
in wells without target protein or with a control protein, strepta-
vidin (Fig. 1C).
The A domain in C6 is from Omega-AcTx-Hv1b (28), a venom
toxin from the funnel-web spider Hadronyche versuta that is le-
thal to crickets after lateroventral thoracic injection (Fig. 1B).
The B domain in C6 is from JzTX21 (29), a peptide that is from
the tarantula Chilobrachys guangxiensis and that is without a
reported target or function. The C domain in C6 is from Hm2
(30), a venom toxin from crab spider Heriaeus melloteei that can
inhibit the voltage-gated sodium channel Nav1.4 with an IC50 of
∼150 nM. The predicted C6 peptide was synthesized for study.
Two C6 Bind to Dimeric hHv1 Channels with Positive Cooperativity.
C6 was isolated by binding to the purified hHv1 protein, which
has been shown to be monomeric at the nanomolar concentra-
tions employed in our panning condition (Materials and Methods)
(27), rather than the full-length channel expressed in the native
milieu of a cellular plasma membrane. We therefore sought
evidence for C6 binding to intact hHv1 channels expressed in live
HEK293T cells using smTIRF. The N terminus of C6 was la-
beled with the red fluorophore carboxytetramethylrhodamine
(TAMRA-C6) and the C terminus of hHv1 was tagged with teal
fluorescent protein (hHv1-TFP, Fig. 2A). Incubation of TAMRA-C6
with cells expressing hHv1-TFP produced particles containing
both fluorescent colors at the cell surface (Fig. 2B). Cells subjected
to illumination to achieve fluorophore bleaching allowed counting
of the number of Hv1-TFP subunits and molecules of TAMRA-
C6 present in each particle by methods we have described pre-
viously (31–33).
Two stepwise decreases in fluorescence were seen in 88% of
particles with hHv1-TFP (Fig. 2 B and C and SI Appendix, Table
S2), supporting other evidence that the majority of hHv1 channels
are dimeric (34, 35). Consistent with fluorophore prebleaching
and missed events at the time resolution of smTIRF system (31),
we observed ∼10% of particles with single hHv1-TFP bleaching
events. To validate our estimate of two subunits in hHv1 channels,
we applied the statistical approach of Hines for inferring stoichi-
ometry from photobleaching studies (36) to assess the probability
of observing each fluorescence event (θ) and determined the con-
fidence (estimated likelihood) that our conclusion was accurate to
be >0.999 (SI Appendix, Table S2).
To measure the binding affinity of TAMRA-C6 toxin for
hHv1-TFP channels, we varied the concentration of TAMRA-
C6 applied to hHv1-TFP channels expressed in HEK293T cells.
smTIRF was used first to study single fluorescent particles with
both fluorophores to determine the fractional occupancy of
channels by C6 on a pixel-by-pixel basis. When only 0.01 nM
TAMRA-C6 was applied, surface particles of hHv1-TFP with
Fig. 1. C6 is isolated from an ICK scaffold, phage-
display library. ICK scaffold phage library construc-
tion, hHv1 protein purification, phage preparation,
and sorting are described in Materials and Methods.
(A) Library design and phage sorting. A total of 110
ICK toxin sequences was aligned on conserved Cys
residues (indicated by the gray highlighting) to de-
fine three domains that correspond to ProTx-II resi-
dues Tyr1–Thr8, Asp10–Val20, and Arg22–Trp30,
respectively. Black lines indicate the arrangement of
disulfide bridges. This yields 95, 104, and 106 unique
A, B, and C domains, respectively (SI Appendix, Table
S1), that combine to produce a calculated library
diversity of ∼1 million for all natural and novel ABC
peptides. After five rounds of selection on hHv1 pro-
tein, phage enrichment was observed compared with
the streptavidin control. (B) Corza6 (C6) is a novel toxin isolated from the library screening. DNA sequencing revealed that C6 toxin phage had been enriched after
phage sorting. C6 composed of residues present in three natural parental spider toxins, ω-ACTX-Hv1b (red), JZTX21 (green), and Hm2 (blue). (C) ELISA shows
C6 phage binds to hHv1 protein but not control protein streptavidin and ELISA plate (no protein). The 96-well plates coated with or without target protein were
incubated with C6 phage (1010/well). Data are mean ± SD for three wells.
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TAMRA-C6 showed a mean Manders’ colocalization coefficient
(MCC) of 0.11 ± 0.01, indicating ∼11% of hHv1-TFP channels
were associated with at least one TAMRA-C6 peptide. As the
concentration of TAMRA-C6 was increased, the percentage of
particles with both fluorophores increased. At 1 μM TAMRA-
C6, colocalization reached a maximum, showing a mean MCC of
0.94 ± 0.02 (Fig. 2D and Table 1). A dissociation constant (Kd) of
0.75 ± 0.03 nM and a Hill coefficient of 1.52 ± 0.13 were de-
termined from a fit of the dose–response for colocalization with
the following relationship:
f = ½C6h
.
Kdh + ½C6h

, [1]
where f is the fraction of hHv1-TFP colocalized with TAMRA-
C6 at equilibrium, [C6] is the concentration of TAMRA-C6, and
h is the Hill coefficient (Fig. 2D).
A Hill coefficient of 1.5 is consistent with the idea that two
C6 peptides bind to hHv1 channels on two interacting sites (37),
a notion supported by the dimeric channel structure and elec-
trophysiology findings supporting energetic coupling of the
movement of the two voltage sensors (35, 38, 39). Indeed, fitting
the dose–response of hHv1-TFP colocalization with TAMRA-
C6 using the Monod–Wyman–Changeux (MWC) model (Eq.
2) as initially formulated for symmetrically arranged oligomeric
proteins of identical subunits, each of which has one binding site
for a given ligand (40), the first C6 toxin was estimated to bind
with an ∼12-fold lower affinity than a second C6 at two allo-
sterically coupled sites. Thus, when:
f = ð1+ ½C6=K2Þn=ðL0ð1+ ½C6=K1Þn + ð1+ ½C6=K2ÞnÞ, [2]
where f is the fraction of channels occupied by toxin, [C6] is the
concentration of TAMRA-C6 applied, n is the number of sites in
channels that can bind toxin, L0 is the allosteric equilibrium
constant, and K1 and K2 are the apparent equilibrium association
constants for binding of the first and second C6, the MWC
model yields a ratio of K2/K1 ∼12 (Fig. 2E).
Since pixel-by-pixel analysis cannot distinguish between
channels with one or two bound toxins, we sought to explicitly
assess the stoichiometry of colocalization and to quantify the
energetics of cooperativity of C6 binding using single-particle
photobleaching (Table 1). Thus, if binding to each channel site
was independent, site occupancy would be predicted by a simple,
unbiased binomial distribution (41) and the probability (p) of
C6 binding to both subunits of hHv1 would follow (Eq. 3):
p=

n
i

f ið1− f Þn−i, [3]
where f is the fraction of channels with C6 bound, n is the num-
ber of binding sites, and i is the number of bound C6. At low [C6]
in the case of independence, most channels would have 0 bound
toxin and few would have 1 site occupied. In contrast, positive
cooperativity that improves binding affinity at a second site
would produce channels with two C6 peptides even at low [C6].
When 0.1 nM TAMRA-C6 was applied, only 23 of 200 hHv1-
TFP particles confirmed to be intact dimeric channels (because
they show two TFP bleaching steps) colocalized with TAMRA-
C6 (Table 1). According to independent binding (Eq. 3), the
probability that hHv1 channels carry one C6 (n = 2, i = 1) is 20%
and two C6 (n = 2, i = 2) is 1.3%. In contrast, we observed only
3% of channels with one C6 and 8.5% with two C6 demonstrating
binding the first C6 raised the probability for a second C6 binding.
Increasing the concentration of TAMRA-C6 to 1 nM, increased
the fraction of channels with toxin to 60%, and we still observed
only 7% of channels with one C6 bound rather than the 48%
predicted by Eq. 3.
The affinity difference between the two binding events can be
estimated from the excess binding of two C6 using Eq. 4:
Fig. 2. C6 binds to cell surface hHv1 channels po-
tently and cooperatively. C6 peptide was synthe-
sized and labeled with red fluorophore carboxy-
tetramethylrhodamine (TAMRA-C6) and studied
with hHv1 tagged with teal fluorescent protein
(hHv1-TFP) in HEK293T cells by smTIRF microscopy as
described in Materials and Methods. (A) Cartoon
showing two TAMRA-C6 peptides binding on two
subunits of an hHv1-TFP–tagged channel. (B, Left)
Incubation of TAMRA-C6 (red) with heterologous
expressed hHv1-TFP (teal) results in single colo-
calized particles (white) with both TAMRA and TFP
fluorescence at the surface of cells. (B, Center)
Montage of photobleaching time course of a single
fluorescent particle (indicated by arrow in Left),
during continuous excitation to bleach the fluo-
rophores. Every fifth frame is shown. (B, Right) Time
courses for simultaneous photobleaching of both
fluorophores in the representative colocalized par-
ticle, showing two stepwise changes in fluorescence intensity for hHv1-TFP and TAMRA-C6 (arrows). (C) Histogram of photobleaching steps for hHv1-TFP (teal
bars) simultaneously photobleached with 1 nM TAMRA-C6 (red bars). Eighty-eight percent of studied particles with hHv1-TFP were bleached in two steps. The
data analyzed by the approach of Hines estimate hHv1 channels in surface particles formed with two subunits, with an estimated confidence of >0.999 (SI
Appendix, Table S2). Among all colocalized particles containing both fluorescent colors, 88% have two TAMRA-C6 bleaching steps at 1 nM TAMRA-C6 (Table
1). (D) Titration with increased concentration of TAMRA-C6 onto hHv1-TFP results in increasing fractional colocalized fluorescent particles quantitated using
mean MCC. The dose–response is fitted to Hill relationship to obtain a dissociation constant Kd = 0.75 ± 0.03 nM with a Hill coefficient of 1.52 ± 0.13. Each
data point represents the mean ± SEM for three to five cells studied in each condition. (E) Dose–response for hHv1 titrated with TAMRA-C6 at increasing
concentrations was fitted to allosteric Monod–Wyman–Changeux (MWC) model (Inset). In the model, the first C6 binds to one subunit of hHv1 with equi-
librium association constant K1. Binding of C6 converts hHv1 subunits from state□ to the ○ state. The second C6 binds to the other subunit with equilibrium
association constant K2. Fitting yields K1 = 3.74 ± 1.12 nM, K2 = 0.31 ± 0.07 nM, and gives an allosteric equilibrium constant L0 = 9.50 ± 0.99. The ratio of K2/K1
is 12. When performing nonlinear curve fitting, an adjusted r-square value can be obtained for estimating the goodness of fit. The closer the fit is to the data
points, the closer r-square will be to the value of 1. For fitting with MWC model, an adjusted r-square value of 0.9977 was obtained. (F) The colocalization of
TAMRA-C6 with hHv1 decreases with membrane depolarization. At a RMP of −49.1 ± 3.6 mV, the mean Manders’ coefficient of colocalization of TAMRA-
C6 was 0.91 ± 0.03 at 10 nM, and this decreased to 0.61 ± 0.06 when 1 nM was applied (Table 1). When the RMP increased to −7.4 ± 0.9 mV (by changing bath
KCl), 1 nM TAMRA-C6 yielded a Manders’ coefficient of 0.29 ± 0.04, corresponding to an approximately threefold decrease in toxin affinity.
Zhao et al. PNAS | vol. 115 | no. 50 | E11849
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Kpred

Kobs =

1− ppred

pobs
.
ð1− pobsÞppred, [4]
where ppred is the probability of two bound C6 toxins by Eq. 3,
pobs is the probability of two bound C6 toxins based on observed
smTIRF counting, Kpred is the dissociation constant predicted
without cooperativity, and Kobs is the dissociation constant cal-
culated from the observed bias of C6 binding by smTIRF, reflect-
ing the higher affinity of the second site. This yields an affinity
difference Kpred/Kobs of approximately sevenfold. The difference
in free energy between the two binding events is thus ∼1.2 kcal/mol
according to Eq. 5:
ΔΔG=RT   ln

Kpre

Kobs

, [5]
where R is the gas constant and T is the temperature in kelvin.
One C6 Binds to Monomeric hHv1 Channels. hHv1 was engineered to
suppress formation of dimeric channels by shortening the N
terminus and removing the coiled-coil domain at C terminus
(Materials and Methods); these channels remained operational
when truncated and tagged with mTFP1 (ΔhHv1-TFP) (SI Ap-
pendix, Fig. S1A). ΔhHv1-TFP showed one stepwise decrease in
fluorescence in 89% of cases consistent with one channel sub-
unit, while 8% of channels were still dimeric (SI Appendix, Fig.
S1 A and B and Table S3), as expected (27). With 1 nM TAMRA-
C6, 51% of the ΔhHv1-TFP particles colocalized with TAMRA-C6
fluorescence, and bleaching revealed one bound TAMRA-C6
peptide in each case (SI Appendix, Fig. S1B and Table S3). A fit
of the dose–response for ΔhHv1-TFP with TAMRA-C6 according
to Eq. 1 offered a Kd of 1.08 ± 0.13 nM and a Hill coefficient of
1.02 ± 0.14 (SI Appendix, Fig. S1C).
C6 Affinity for hHv1 Decreases with Membrane Depolarization. The
affinity of known VSD toxins depends on changes in voltage
sensor configuration in response membrane potential (15, 42).
To evaluate the influence of potential on C6 binding, we assessed
smTIRF colocalization of TAMRA-C6 and hHv1-TFP in HEK293T
cells at different resting membrane potential (RMP) by altering ex-
tracellular potassium concentration. Cells expressing hHv1 channels
had an RMP of −49.1 ± 3.6 mV in bath solution without added KCl
and were depolarized to −7.4 ± 0.9 mV by isotonic replacement of
100 mM NaCl with 100 mM KCl. Application of 1 nM TAMRA-C6
under the two conditions showed colocalization with dimeric hHv1-
TFP channels to decrease from 61 to 29% with depolarization,
yielding a new calculated Kd of ∼2 nM according to Eq. 1, consistent
with an approximately threefold decrease in affinity (Fig. 2F and
Table 1).
C6 Inhibits hHv1 Proton Currents. HEK293T cells expressing hHv1
generated outward H+ currents in response to depolarizing steps
that we measured using whole-cell patch-clamp recording, and as
described by others (6, 43, 44), we observed slow activation and
fast deactivation kinetics (Fig. 3A). To generate sufficiently large
currents to study C6 blockade, hHv1 currents were generated by
steps lasting 1.5 s to +40 mV from a holding voltage of −80 mV
every 10 s with a 10-fold proton gradient (pHin = 6.5 and pHo =
7.5). Incubation with 250 nM C6 decreased hHv1 currents
∼45%, and the kinetics of channel activation and deactivation
were slowed and speeded by 1.5- and 1.6-fold, respectively (Fig.
3A). Consistent with greater affinity for closed states, 250 nM
C6 shifted the half-maximal activation voltage (V1/2) by +20 mV,
and the extent of inhibition was greater at more hyperpolarized
potentials (i.e., ∼80% at 0 mV; Fig. 3B). C6 blocked hHv1 reversibly
with association and dissociation constants determined by single-
exponential fits to the time course for block and unblock on acute
application and washout of 250 nM C6 (Materials and Methods) to
yield block parameters of Kon = 3 × 10
5 ± 0.8 × 105/M·s and Koff =
0.022 ± 0.001 s−1, respectively (Fig. 3C). C6 inhibited hHv1 currents
in a dose-dependent manner as expected from smTIRF binding
studies. A fit of the dose–response at 40 mV with Eq. 1 yielded a
Ki = 30.9 ± 3.4 nM and a Hill coefficient of 0.48 ± 0.04 (Fig. 3D).
Supporting the specificity of C6 for hHv1, the proton channel
from the sea squirt Ciona intestinalis, CiHv1, was insensitive to
1 μM C6 (Fig. 3D) despite its homology to hHv1 (44). Similarly,
Table 1. Parameters of single-molecule photobleaching with hHv1-TFP and TAMRA-C6 by smTIRF
Analysis
Subunits expressed and concentrations
hHv1-TFP (WT)
0.01 nM
TAMRA-C6
0.1 nM
TAMRA-C6
1 nM
TAMRA-C6
10 nM
TAMRA-C6
100 nM
TAMRA-C6
1 μM
TAMRA-C6
1 nM
TAMRA-C6,
100 mM KCl
Manders’ coefficient 0.11 ± 0.01 0.14 ± 0.01 0.61 ± 0.06 0.91 ± 0.03 0.93 ± 0.05 0.94 ± 0.02 0.29 ± 0.04
Particles studied
Total 151 221 114 63 62 125 179
With 2 TFP (dimeric hHv1) 133 200 100 56 55 113 161
With TFP and TAMRA 10 23 60 50 50 105 50
Dimeric hHv1 with one C6 3/133 6/200 7/100 5/56 3/55 8/113 9/161
Dimeric hHv1 with two C6 7/133 17/200 53/100 45/56 44/55 90/113 41/161
Dimeric hHv1 with three C6 0/133 0/200 0/100 0/56 1/55 4/113 0/161
Confidence 0.83 0.98 0.999 0.999 0.999 0.999 0.99
θ 0.89 0.89 0.96 0.96 0.97 0.96 0.96
θ + 1 0.57 0.58 0.64 0.64 0.64 0.64 0.64
hHv1-TFP was expressed in HEK293T cells and incubated with varying concentrations of TAMRA-C6 toxin for reaching equilibrium. Simultaneous, two-
color, single-particle photobleaching was studied by TIRF (Materials and Methods). Mean Manders’ coefficient for colocalization was generated by using
unbiased intensity correlation analysis as described inMaterials and Methods. The number of colocalized particles and photobleaching steps observed for TFP
and TAMRA fluorophores in each single fluorescent spot were reported and used for quantitating the cooperative binding of C6. Statistical analysis was
performed according to methods described by Hines (Materials and Methods). The statistical confidence in the null hypotheses that two TAMRA-C6 bind to
hHv1 channel was greater than 0.83. Prebleaching and variance in quantum efficiency reduce the probability of observing each possible bleaching event (θ).
θ is calculated from the value of n and the distribution of the photobleaching data per Hines. θ is decreased when the distribution is altered to estimate the
possibility that higher numbers of missed bleaching steps, for example, θ + 1, indicating that this stoichiometry is less likely. Three TAMRA steps at high
concentrations of applied TAMRA-C6 are thought to represent nonspecific or chance association of the third peptide within a diffraction-limited spot.
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1 μM C6 did not inhibit Kv2.1, a channel targeted by a variety of
ICK toxins, nor Nav1.4, a channel inhibited by Hm2, the donor
of the C domain of C6 (SI Appendix, Fig. S2). Consistent with
these findings, incubation of 1 μMTAMRA-C6 with cells expressing
CiHv1 tagged with mTFP1 (CiHv1-TFP) showed no colocalization
using smTIRF studied as in Fig. 2D (n = 100 channel particles).
C6 Binds to the External S3–S4 Loop of hHv1.Many ICK toxins bind
to the S3–S4 loops of VGICs to impede VSD movement. To
confirm that the S3–S4 loop of hHv1 provided the binding epi-
tope for C6, we used sites homologous to those Swartz and co-
workers (9) had demonstrated allowed transplantation of S3–
S4 loops between VGICs to create functional channel chimeras.
Indeed, functional channels were produced when the loop resi-
dues I183 to L204 (numbered according to hHv1) were trans-
planted between CiHv1 and hHv1 (Fig. 4A). Application of 1 μM
C6 to hHv1 carrying the S3–S4 loop of CiHv1 (CiS3-S4hHv1)
showed the channel to be insensitive to the toxin like CiHv1 (Fig.
4B). In contrast, transplanting of S3–S4 loop from hHv1 into
CiHv1 (hS3-S4CiHv1) conferred C6 toxin sensitivity to the chi-
mera with a Ki of 35 ± 14 nM, a sensitivity like that measured for
WT hHv1 under the same study conditions (Fig. 3D). Supporting
the conclusion that the hHv1 S3–S4 loop is the major binding
epitope for C6 in H+ channels, transplanting of S1–S2 loop of
hHv1 into the corresponding region of CiHv1 did not confer
C6 toxin sensitivity (SI Appendix, Fig. S3) whereas transplanting
the S3–S4 loop of hHv1 into the human Kv2.1 potassium channel
again conferred inhibition by C6 (SI Appendix, Fig. S4).
C6 Blocks the Acrosome Reaction via Inhibition of hHv1 During
Capacitation. Human sperm capacitation has been argued to re-
quire H+ efflux via hHv1 to alkalinize the cytoplasm, promoting
Ca2+ influx via CatSper, and membrane hyperpolarization (Fig.
5A) (18, 45). To test this hypothesis, we first sought to confirm
that C6 could suppress hHv1 in human sperm. The proton cur-
rents were recorded by whole-cell patch clamp in mature human
spermatozoa, as described previously (18). As expected, 1 μM
C6 slowed proton current activation, speeded deactivation, and
decreased H+ current amplitude with a calculated Ki of 1.0 ±
0.3 μM. In contrast, the control peptide KTx* (16) had no effect
on the currents, and as reported by Lishko et al. (18), the current
was inhibited by Zn2+ ions (Fig. 5B).
It is well established that progesterone can trigger the acro-
some reaction only in capacitated spermatozoa. Hence, to assess
the role of hHv1 in this process, human spermatozoa were in-
cubated under capacitating conditions in the presence of 20 μM
KTx* or C6 for 3–4 h. Afterward, the cells were stimulated with
progesterone to induce acrosomal exocytosis. While sperm in-
cubated with control peptide reacted normally, showing exo-
cytosis using FITC-coupled Pisum sativum agglutinin, those
exposed to C6 were inhibited ∼70% (Fig. 5C). Inhibition was
judged to be on capacitation and not exocytosis because
C6 did not suppress when sperm were first capacitated and
then incubated for 30 min with peptide before stimulation
with progesterone (SI Appendix, Fig. S5). C6 did not alter
viability nor motility of the sperm, indicating that the effect
was not due to peptide toxicity (Fig. 5 C and D). Moreover,
the toxin affected specific aspects of capacitation; for example, it
did not alter the tyrosine phosphorylation pattern, a measure of the
phosphorylation-signaling pathway crucial to capacitation (SI Ap-
pendix, Fig. S6).
The proposed role of hHv1 H+ efflux is to permit Ca2+ influx
via CatSper, the only channel that mediates Ca2+ entry into
mature spermatozoa (46–48). In support of this mechanism,
20 μM C6 inhibited the rise in cytoplasmic Ca2+ observed with
progesterone stimulation using fluorescent Ca2+ indicator Fluo-
3, while the control peptide had no effect (Fig. 5E). To confirm
that C6 did not alter Ca2+ influx by direct interaction with CatSper,
the effect of EGTA on sperm RMP was studied; EGTA chelates
extracellular Ca2+ promoting Na+ influx through CatSper resulting
in membrane depolarization (49, 50). The same C6 concentration
that suppressed the progesterone-induced rise in intracellular Ca2+
Fig. 3. C6 specifically inhibits hHv1 proton currents. hHv1 and CiHv1 channels
were expressed in HEK293T cells and studied by whole-cell patch clamp to
assess block parameters using a holding voltage of −80 mV, 1.5-s test pulses,
and a 10-s interpulse interval, with pHi = 6.5 and pHo = 7.5. Values are mean ±
SEM; n = 6–12 cells for each condition. (A) Representative proton current traces
for hHv1 channels before (Left), and in the presence of 250 nM C6 (Right) with
steps of 10 mV from −80 to 50 mV. The tail current measured immediately fol-
lowing depolarization was used to determine the extent of block. Fitting the ac-
tivation and deactivation of proton currents at 40 mV to a single exponential
function gave time constants τact of 1,528± 116 and 2,183± 173ms, τtail of 109.2±
12.4 and 67.8 ± 9.0 ms without and with C6, respectively. (B) Conductance–voltage
relationships (G–V) for hHv1 (■ ) in the absence or presence of 250 nM C6 (red,
■ ). Curves are fitting to the Boltzmann equation. (C) The time course for block
and unblock of hHv1 on acute application (red bar) and washout of 250 nM C6.
Currents were recorded at 40mV. (D) Dose–response relationships for C6 inhibition
of hHv1 (■ ) and CiHv1 (♦). The inhibition constant Ki of C6 for hHv1 channels
was estimated from the fit to Eq. 1 and was 30.9 ± 3.4 nM with a Hill coefficient
of 0.48 ± 0.04; the maximum inhibition by C6 at +40 mV was 50% of unblocked
current. CiHv1 is insensitive to C6 at all tested concentrations up to 1 μM.
Fig. 4. The S3–S4 loop of hHv1 is the binding epitope for C6. hHv1, CiHv1,
and chimera channels were expressed in HEK293T cells and studied as de-
scribed in Fig. 3. (A) Sequence alignments of the S3–S4 motif of hHv1 (black),
CiHv1 (blue), and loop transplanting chimeras. The S3–S4 loop of hHv1 or
CiHv1 were transplanted into the corresponding region of CiHv1 or hHv1 to
produce functional chimeric channels, hS3-S4CiHv1 and CiS3-S4hHv1, respec-
tively. (B) Representative proton current trace for channels (black trace) in
the absence or presence of 1 μM C6 (red trace, inhibition at +40 mV after
toxin wash-in as indicated by red arrows). Left, CiHv1; Center, CiS3-S4hHv1;
Right, hS3-S4CiHv1. The S3–S4 loop of hHv1 can be transplanted to CiHv1 to
confer toxin sensitivity in hS3-S4CiHv1 chimeric channel.
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did not alter the EGTA-induced change in RMP, demonstrating
that C6 did not block CatSper channel (Fig. 5F and SI Appendix,
Fig. S7).
C6 Inhibits ROS Production in Human WBC. In mouse, mHv1 has
been demonstrated to regulate nicotinamide adenine dinucleotide
phosphate (NADPH)-dependent oxidase enzymes (NOX) that
produce ROS (20, 23). Thus, oxidation of NADPH to NADP+ by
NOX is electrogenic, leading to membrane depolarization and
cytoplasmic acidification that attenuates production of ROS dur-
ing the respiratory burst in neutrophils frommHv1−/−mice lacking
the channel. Seeking evidence for the same mechanism in human
WBCs, we studied H2O2 production induced by PMA activation
of protein kinase C (PKC) to stimulate respiratory burst using a
standard fluorescent assay (20, 21). Consist with expectations, both
Zn2+ and 1 μMC6 inhibited H2O2 production, whereas the effect of
control peptide was negligible (Fig. 6A). Fitting a dose–response
relationship for C6 with Eq. 1 yielded a Ki of 37.2 ± 5.9 nM and a
Hill coefficient of 0.63 ± 0.07 (Fig. 6B), supporting the conclusion
that hHv1 plays an essential role in human WBCs, as mHv1 does
in mice, extruding protons during respiratory burst to permit
sustained superoxide production.
Discussion
Peptide Toxins Targeting Orphan VSD-Containing Proteins. Venom
toxin peptides are among the most powerful tools in the arsenal
for the investigation of membrane receptors and are now used as
well for diagnosis and treatment of disease (51, 52). Limiting
broader use, most receptors of interest lack a recognized peptide
that binds with high affinity and specificity. We have previously
employed scaffold-based phage-display toxin libraries to produce
specific inhibitors that bind in the ion conduction pores of po-
tassium channels. The scorpion α-KTx scaffold was used first to
design a library with ∼104 novel variants and identify Moka1,
a toxin with high-affinity and improved specificity for human
Kv1.3, which suppresses CD3/28-induced cytokine secretion by
T cells without cross-reactive gastrointestinal hyperactivity (16).
Subsequently, we constructed a library based on the SAK1 sea
anemone toxin scaffold at library diversity of ∼106 and identified
Hui1, a potent and specific inhibitory toxin, and HmK, a potent
but promiscuous native toxin, for KcsA, an “orphan” channel
without previously known ligands (17). In addition to pore-
occluding toxins, voltage-gated channels can be activated or
inhibited by gating modifier toxins, which stabilize the VSD in
different conformations (11–13). In this work, we create a library
with ∼106 variants based on the ICK toxin scaffold, a backbone
found in many natural toxins that target the VSDs of voltage-
gated channels. We anticipated that the ICK library would allow
selection for peptides that targeted orphan receptors like hHv1
lacking useful regulatory ligands. Here, we describe C6, a de novo
toxin containing domains from parental natural toxins in three
different species of spiders, isolated by binding of phage to hHv1.
The diverse biological roles of hHv1 make it an important
channel to understand and a potential pharmaceutical target.
The isolation of C6 for hHv1 using an ICK scaffold (this work),
Moka1 for Kv1.3 using an α-KTx scaffold (16), and Hui1 for
KcsA on a SAK1 scaffold (17) demonstrates that scaffold-based
target-biased libraries and high-throughput phage-display selec-
tion allows identification of specific, high-affinity regulators for
ion channels targeting their pores and regulatory domains. This
supports the notion that other toxin scaffolds should allow ligand
selection for other classes of membrane receptors targeted by pep-
tide neurotoxins that are important to human health and disease.
C6 Is an Advanced Tool for Studying hHv1. Indirect evidence has
implicated hHv1 in a variety of cellular functions including
sperm capacitation, ROS production, and cell proliferation in
cancer, but without a known high-affinity and specific ligand
confirmation of the roles of the channel and mechanistic inquiry
have in some cases been impeded (1). The few reported inhibi-
tors of hHv1, although employed productively, are pharmaco-
logically promiscuous or of low affinity, and include external
Zn2+ ions (8) and HaTx1, the spider toxin that blocks numerous
VGICs including Kv2.1, Kv4.2, Nav1.2, and Cav2.1 (9, 12), and
guanidinium derivatives that block from the inside of the mem-
brane (10). C6 has proven to be a valuable tool for studying
hHv1 first because it binds to the external VSD loop in
hHv1 with a Kd ∼1 nM at the natural, hyperpolarized RMP of
Fig. 5. C6 inhibits hHv1 in human spermatozoa and
suppresses the acrosome reaction. As described in
Materials and Methods, mature human spermatozoa
were collected and recorded by whole-cell patch
clamp, or studied by light or fluorescent microscopy.
In C–F, values are mean ± SEM for three separate
experiments. (A) Schematic representation of syner-
gistic cooperation of hHv1, NOX5, and CatSper in
human sperm activation as proposed (54, 62). CatSper
is activated by progesterone leading to Ca2+ influx.
The Ca2+-activated NADPH oxidase 5 (NOX5) catalyzes
the translocation of electrons across the plasma mem-
brane, increasing the concentration of H+ in the cyto-
plasm. The extrusion of H+ through hHv1 maintains
physiological pH in the cytoplasm. Blocking hHv1 by
C6 is predicted to cause cytosolic acidification, de-
creasing CatSper activity. (B) Proton current via hHv1 in
human sperm. Representative current traces in re-
sponse to a test pulse from −80 and 100 mV, in 20-mV increments, in the absence and presence of 1 μM C6 are shown. Inhibition by 1 μM Zn2+, 1 μM C6, and
1 μM control peptide (KTx*) on sperm hHv1 current and measured at the end of the test pulse to 100 mV is plotted. Values are mean ± SEM; n = 4 cells for each
condition. (C) Human spermatozoa were incubated with or without peptides during capacitation, and the acrosome reaction was triggered subsequently by
progesterone. After progesterone stimulation, control sperm (black) underwent the acrosome reaction. KTx* (20 μM, gray) did not affect the acrosome re-
action, whereas C6 (20 μM, red) caused a ∼70% inhibition of the exocytic process. Data were evaluated using Tukey’s multiple-comparison posttest for paired
comparisons for means. ns, indicates that statistical differences between control and treated samples were nonsignificant (P > 0.05), ***P < 0.001. (D) The
viability and motility of sperm were measured for velocity straight line (VSL), progression (PROG), and velocity average path (VAP). Sperm incubated with
C6 showed no significant difference in viability or motility. (E) Human spermatozoa were incubated with or without peptides during capacitation, and then
activated with progesterone, and the increase of cytosolic calcium triggered by progesterone was measured. The relative fluorescence (RF) change with
progesterone decreased ∼60% in the presence of 20 μM C6. Control peptide KTx* had no effect on calcium signaling, *P < 0.05. (F) The effect of C6 on CatSper was
evaluated by measuring membrane potential change (Δ MP) after adding EGTA to chelate external Ca2+ and allow Na+ to permeate through CatSper, depolarizing
the sperm. The ionophore valinomycin shifts the membrane potential of the sperm to the Nernst potential for potassium as previously reported (50). ΔMP represents
the difference between membrane potential before and after EGTA addition.
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mammalian cells. Second, whereas many ICK toxins modulate
more than one VGIC subtype, thus far, C6 appears to be specific
to hHv1 since it does not cross-react with exemplar potassium
and sodium VGICs (Kv2.1 and Nav1.4), CiHv1, or Catsper in
human sperm. As in our prior studies on de novo toxins that
target potassium channels, C6 is a third example of achieving
target specificity by driving selection for high affinity.
C6 Establishes the Role of hHv1 on Capacitation of Human Sperm.
Capacitation is a requirement for sperm to undergo the acro-
somal reaction and to develop hyperactivated motility, two
necessary conditions for fertilizing an egg (53). It is hypothesized
that hHv1, the Ca2+-activated enzyme NOX5, and CatSper form
a synergistic network in the human sperm plasma membrane that
regulates intracellular pH, redox potential, and cytosolic free
Ca2+ concentration, which are all crucial for sperm capacitation
(2). Lishko et al. (18) presented strong evidence that sperm
function depends on proton efflux via hHv1 to induce in-
tracellular alkalization using nonspecific inhibitors like Zn2+,
noting however that this role for hHv1 could not be confirmed
without a reagent that specifically blocks the channel. Moreover,
the model for human sperm cannot be supported using mHv1−/−
mice since they are fertile indicating that a different mechanism
is operating in this species (20, 23, 24). Here, we employed C6 to
study human sperm to show that the activity of hHv1 channels is
necessary during capacitation to allow the intracellular calcium
rise and acrosomal reaction stimulated by a physiological inducer
for fertilization, as proposed by Lishko et al. (18).
C6 Confirms the Role of hHv1 Role in ROS Production by Human WBCs.
Oxidation of NADPH to NADP+ by NOX enzymes transports
electrons across the cell membrane to reduce oxygen to super-
oxide, with subsequent conversion to H2O2, a process essential to
innate immunity (54). This physiological process of ROS pro-
duction leads to membrane depolarization and intracellular acid-
ification (24, 55). To sustain the cascade in mice, mHv1 is required
to extrude protons to maintain cytoplasmic pH in the physiological
range and contribute to membrane repolarization, a mechanism
confirmed using a knockout strategy (20, 23, 24). Here, we dem-
onstrate the required role for hHv1 operation in human WBCs,
using C6 to suppress high-level superoxide production during the
respiratory burst induced by PMA.
C6 Inhibition, a Cooperative Voltage-Dependent Mechanism. The
affinity of C6 for hHv1 decreases with depolarization. At −50 mV,
smTIRF shows that incubation of HEK293T cells with 1 nM
C6 yields 53% of hHv1 channels with two bound toxins, 7% with
one toxin, and 40% with no toxin (Table 1), indicating a KD of
0.75 nM and positive cooperativity of toxin binding to the closed
channel state. After a step lasting 1.5 s to 40 mV, the KD increases
40-fold to 30 nM as judged by current inhibition, and blockade is
partial, reaching just 50% with 1 μM C6 in the bath (Fig. 3D).
These observations are consistent with the action of ICK toxins
that alter VGIC gating by binding to VSDs described by the re-
search groups of Bezanilla (56), Swartz (42), and Catterall (57)
where the outward movement of the S4 segment accelerates the
dissociation of the toxins from their target sites and thus binding
affinity correlates closely with the membrane potential and gating
states of VGICs (13). As seen with other gating modifier toxins
that bind with greater affinity to closed channels, C6 slows the
channel activation, speeds deactivation, and shifts the voltage
dependence of activation to more positive potentials. Our results,
and the operation of other gating-modifying toxins, point to a model
in which C6 binding to hHv1 is favored in the “down” conformation
of the VSD.
We have shown that hHv1 has two C6 binding sites, one on the
S3–S4 loop of each subunit, and that the binding of the first
C6 increases the affinity of the second site for C6. Because
monomeric ΔhHv1 channels are able to bind one C6 without
evidence of an allosteric effect, the positive cooperativity for
binding to dimeric hHv1 channels represents either attraction
between the two peptides or, as we suspect, intrinsic coopera-
tivity of gating between two subunits of the hHv1. Thus, attaching
a fluorophore to the S4 segments of hHv1 channels (altered to
open more readily) has demonstrated that movement of one voltage
sensor in hHv1 accelerates the movement of the other such that the
two pores tend to be in the same state, open or closed (38). There-
fore, we favor the idea that binding the first C6 favors the closed
state of both its own VSD receptor and the trans site on the other
subunit, improving the energetic favorability of the second bind-
ing reaction (by ∼1.2 kcal/mol in HEK293T cells as studied for
smTIRF). Similarly, we interpret the apparent negative coopera-
tivity for C6 inhibition at +40 mV to reflect coupled opening of
the two pores at the positive membrane potential, favoring dis-
sociation of the second C6 once the first toxin has left its site.
Tombola et al. (38) reported that the two hHv1 subunits in
dimeric channels (mutated to activate at more hyperpolarized
potentials than WT) show intersubunit interactions so robust
that the second subunit was ∼60 times more likely to open when
the other subunit was already open. Subsequently, Tombola and
coworkers (58) found that the 2-guanidinothiazole derivative
GBTA inhibited open hHv1 channels by binding cooperatively in
the intracellular cavities of both subunits at +120 mV, inter-
preting the binding of GBTA to one subunit to increase in
binding affinity of the neighboring subunit with a difference
Fig. 6. C6 inhibits ROS production in human WBC during respiratory burst.
As described in Materials and Methods, H2O2 produced by human WBCs in
response to PMA was measured spectrophotometrically. Values are mean ±
SEM from two independent experiments performed in triplicate. (A) H2O2
produced 40 min after PMA stimulation. Preincubation with 100 μM Zn2+ or
1 μM C6 decreased ROS production, while 10 μM KTx* had no effect. (B)
Dose–response for C6 inhibition of ROS production fit to Eq. 1 yielded a Ki of
37.2 ± 5.9 nM and a Hill coefficient of 0.63 ± 0.07.
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between the binding free energies of the lowest affinity and
highest affinity sites of ∼1.3 kcal/mol, similar to the cooperativity
of external C6 binding we estimate by smTIRF to closed dimeric
hHv1 channels at approximately −50 mV (∼1.2 kcal/mol). These
findings each reflect cooperativity of the closed and the open
states of the two subunits in hHv1.
The mechanism of voltage-dependent C6 blockade of hHv1
merits further elucidation, for example, to compare it with the
action of native ICK toxins on VGIC (42) and, particularly, as it
relates to inhibition of the proton channels as they operate in
sperm and WBCs because the membrane potentials of the native
cells change with activity. At baseline, the RMP of human sperm
is −40 mV and it drops to −60 mV with capacitation (45), thus
remaining hyperpolarized at potentials where C6 is expected to
block with high affinity and positive cooperativity. In contrast, the
RMP of neutrophils is estimated to be −60 mV and it rises to
60 mV on activation (59), indicating that C6 blockade will be more
effective before NADPH oxidase activity increases during respira-
tory burst, depolarizing the cells, diminishing the affinity of C6 for
hHv1 channels.
Materials and Methods
Library Construction and Screening. The sequence of natural spider toxin
ProTx-II was used as a template for selecting 110 parent toxins sequences
from a BLAST search of the UniProt database as previously described (17, 60).
Sequences were aligned based on the six conserved cysteine residues that
form disulfide bridges and the ICK scaffold. Three domains were defined by
the second and fifth conserved cysteine, allowing for insertions and dele-
tions, and 110 ICK scaffold toxins give 95, 104, and 106 unique A, B, and C
domains, respectively. Nucleotide duplexes encoding the second and fifth
cysteine were ligated unidirectionally to produce toxin genes with only the
correct domain order. Separate reactions were preformed to ligate the gene
inserts into pAS62 in frame with M13 filamentous phage particle coat pro-
tein pIII. Ligation mixtures were transformed into SS320 electrocompetent
cells and sequencing of 376 plaques confirmed unbiased insert utilization.
Library phages and single toxin phages were prepared as previously de-
scribed (16).
hHv1 protein (hHv1-VSD, residues 75–223) was purified as previously
described (27). hHv1 protein was biotinylated using sulfosuccinimidyl 2-
(biotinamido)-ethyl-1,3-dithiopropionate (EZ-Link Sulfo-NHS-SS-Biotin; Thermo
Scientific). Biotinylation was verified by a pull-down assay using streptavidin
MagneSphere beads (Promega). The 500 nM biotinylated hHv1 protein was
adsorbed to 100-μL streptavidin MagneSphere paramagnetic particles, and
free streptavidin-binding sites were blocked with biotin to prevent non-
specific binding. Beads were washed four times with TBS (25 mM Tris·HCl,
140 mM NaCl, and 3 mM KCl, pH 7.4) containing 0.1% Tween 20, 1% BSA,
and 2 mM 1-palmitoyl-2-hydroxy-sn-glycero-3-phosphate-(1′-rac-glycerol) (LPPG)
(Avanti Polar Lipids) (TBSTBL). Phage expressing the toxin library diluted to
1010 pfu in 100 μL of TBS containing 0.5% BSA and 2 mM LPPG and mixed
with hHv1 protein adsorbed Magnesphere beads and allowed to bind for 1 h
at room temperature. A KingFisher (Thermo Fisher Scientific) automated mag-
netic bead manipulator was used to wash the beads three to five times with
TBSTBL, so that the poorly adherent phage particles were removed. Tightly
bound phage was detached from the beads using 100 mM DTT. The super-
natant was collected and used to infect log-phase Escherichia coli XL-1 blue
(Stratagene) immediately. Infected E. coli were used for quantification by
titering and for phage amplification.
Alternative rounds of panning were done with NUNC-Immuno MaxiSorp
96-well plates (Thermo Fisher Scientific) that were coated overnight at 4 °C
with 100 mM NaHCO3 and 1 μg/well hHv1 protein to decrease nonspecific
phage enrichment. Wells were washed twice with TBSTBL and then blocked
with TBS containing 1% BSA and 0.2% Tween 20 (TBSTB) overnight at 4 °C.
Wells were washed twice more with TBSTB. Library phage was dilute to
1010 pfu/mL in TBSTBL and added to the wells. Phages were allowed to
bind for 1 h at room temperature. Poorly adherent phage was removed by
washing three to five times with TBSTBL manually. Bound phages were
eluted with 100 μL of 0.1 M triethylamine by incubation for 10 min on a
rocking shaker. The pH of the eluate was adjusted to between 7.0 and 8.5 with
1 M Tris·HCl (pH 8.0). Amplification and titering of phage was done in the
same way as described above. After five rounds of library sorting (three rounds
using MagneSphere with adsorbed biotinylated hHv1 protein, and two rounds
using NUNC-Immuno plates directly coated with hHv1 protein as target),
44 clones were genotyped by DNA sequencing to confirm enrichment.
Toxin Synthesis and Fluorescent Labeling. C6 toxin (MH828728) was purchased
as synthetic peptides from CSBio. Peptide toxin folding reactions were
quenched by acidification and purified by reverse-phase HPLC as before.
Peptides that were more than 95% pure were lyophilized and stored at −20 °C.
Peptides were dissolved in appropriate external solutions for whole-cell patch-
clamp recordings or physiological assays before use.
C6 peptide was labeled with 5-(and-6-)-carboxytetramethyl-rhodamine
succinimidyl ester (5,6-TAMRA-SE) (Life Technologies). C6 was dissolved in
50 mMHepes, 100 mMNaCl at pH 7.5 to 5 mg/mL concentration. 5,6-TAMRA-
SE dye was dissolved in 500 μL of DMSO per manufacturer instructions.
C6 and dye were mixed at a ratio of 1:10 for 1 h at room temperature on a
rotating shaker. The labeled C6 was purified by HPLC over a 20–50% ace-
tonitrile gradient and the corresponding single peak was collected. Samples
were lyophilized and stored at −80 °C. Labeled peptide was dissolved in
appropriate external solution before use.
Molecular Biology. Human Hv1 (NM_001040107) or Ciona intestinalis Hv1
(NM_001078469) tagged with a TFP connected by a 13-residue flexible linker
were constructed using gBlock gene fragments (Integrated DNA Technolo-
gies) and inserted into a laboratory dual-purpose vector pMAX+ using
Gibson Assembly (New England BioLabs). Monomeric human ΔHv1 was
constructed by truncating hHv1 subunit at position 82 for N terminus and
219 for C terminus and was tagged with TFP identically to WT and inserted
into pMAX+. hS3-S4CiHv1 was constructed by replacing the S3–S4 loop
(G231–L254) of CiHv1 with S3–S4 loop (I183–L204) of hHv1. CiS3-S4Hv1 was
constructed by replacing the S3–S4 loop (I183–L204) of hHv1 with S3–S4 loop
(G231–L254) of CiHv1. hS1-S2CiHv1 was constructed by replacing the S1–S2 loop
(L169–L187) of CiHv1 with S1–S2 loop (I121–F139) of hHv1. hS3-S4Kv2.1 was
constructed by replacing the S3–S4 loop (V275–L305) of hKv2.1 with S3–S4 loop
(I183–W207) of hHv1. All chimeras were assembled into pMAX+ using Gibson
assembly (Integrated DNA Technologies). rNav1.4 (NP_037310) carried in vector
pcDNA1 and hKv2.1 (NP_004966) in pMAX+ were used as previously described.
Cell Culture. HEK293T cells were purchased from ATCC and maintained in
DMEM (ATCC) supplemented with 10% FBS and 1% penicillin and strepto-
mycin. Plasmids were transfected into cells using Lipofectamine 2000 (Life
Technologies) according to the manufacturer’s instructions. Experiments
were performed 24–48 h posttransfection.
Two-Color smTIRF for Photobleaching and Analysis of Fluorescence Colocalization
and hHv1 Subunit Stoichiometry. HEK293T cells were seeded on glass-bottom
dishes (Chemglass Life Science) and transfected with hHv1-TFP as described
above. The surface density of channel molecules was kept <200 in 10 × 10-μm
field for minimizing the overlapping of multiple channels within a diffraction-
limited spot. TAMRA-C6 was added in 100 mM Hepes, 100 mM NaCl, 0.5 mM
CaCl2, 1.2 mMMgCl2, and 10 mM glucose, pH 7.5, to the dishes and incubated
adequate times for reaching binding equilibrium. Cells were extensively
washed to remove nonspecifically bound toxins before recording. Single
protein molecules or complexes at the surface of live HEK293T cells were
identified by using TIRF microscope as described (31).
Critical angle for TIRF was adjusted using a CellTIRF illuminator (Olympus)
and a high numerical aperture apochromat objective (150×, 1.45 N.A.)
mounted on an automated fluorescence microscope controlled by Meta-
morph software (Molecular Devices). CellTIRF software (Olympus) was used
to simultaneously illuminate both fluorophores at a critical angle such that
only 100 nm deep was illuminated. TAMRA was excited with the 561-nm
laser line and TFP was excited at a 445-nm laser line. Emitted light signals
were split with a 520-nm dichroic mirror mounted in a DualView adapter
(Photometrics), which allows each wavelength to be directed to one-half of
a back-illuminated EM-CCD. Stoichiometry was assessed by simultaneous
photobleaching with continual excitation. Data were captured as movies of
100–370 frames acquired at 1 Hz. Data were analyzed as previously de-
scribed. When TAMRA was with TFP in the same cell, the data for each
fluorophore were saved as separate stacks and processed in an identical
manner. The Manders’ coefficient of colocalization between fluorophores
was determined by unbiased intensity correlation analysis using the Coloc2
plugin in ImageJ to confirm overlap of the two molecules. Fluorescence mea-
sured from each region was plotted versus time to determine the number of
bleaching steps at each point.
Statistical analyses to calculate estimated confidence with which stoichi-
ometry could be inferred from the observed data and θ, the probability of
successfully observing each possible photobleaching event, were performed
in R Studio, based on methods developed by Hines (36). The densities of
colocalized and single fluorescent spots were determined following thresh-
olding and watershed separation in ImageJ. Then, the particle number was
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counted in separate regions of interest for three to five cells per group by
using the Analyze particles plugin.
Electrophysiology. Proton current from hHv1, CiHv1, and chimera channels
were recorded in whole-cell mode using an Axopatch 200B amplifier.
Stimulation and data collection were done with a Digidata1322A and
pCLAMP 9 and 10 software (Molecular Devices). Cells were perfused with an
external solution of 100 mM Hepes, 100 mM NaCl, and 10 mM glucose at
pH 7.5. Pipettes with resistances between 3 and 5 MΩ were filled with 100 mM
Bis-Tris buffer, 100 mM NaCl, and 10 mM glucose at pH 6.5. Capacitance was
subtracted online. Sampling frequency was 10 kHz and was filtered at 1 kHz.
C6 was applied in 100 mM Hepes, 100 mM NaCl, 10 mM glucose, with 0.05%
fatty acid-free BSA (Sigma) at pH 7.5, and effects were monitored by pro-
tocols evoking current by stepping to 40 mV for 1.5 s from a holding voltage
of −80 mV, with 10 s between any given pulse. Current–voltage relationships
were evoked from a holding potential of −80 mV to test pulses from −80 to
50 mV for 1.5 s in 20-mV intervals every 10 s. Fractional unblocked current
was assessed at the end of the test pulse or immediately after repolarization.
The conductance–voltage relationships were determined as described by
DeCoursey in ref. 61, the reversal potential (Vrev) is calculated with the
equation Vrev = (Iend − Itail)/(Vtest − Vhold) and were fit to the Boltzmann
equation, G = Gmax/[1 + exp(−zF(V − V1/2)/RT)], where V is the test potential,
V1/2 is the voltage of half-maximal activation, z is the effective valence, T is
the temperature, R is the gas constant, and F is the Faraday constant. De-
activation kinetics for Hv1 with and without C6 were determined by fitting
traces with single-exponential functions. Activation kinetics were fit with a
single exponential with a delay. kon and koff were estimated from fits of the
kinetics of toxin wash-in and wash-out and calculated using the following
equations:
τon = ðkon½Tx+koffÞ−1, [6]
and
τoff = ðkoffÞ−1. [7]
A dose–response curve was determined by plotting the fractional unblocked
current, IC6/Icontrol, versus concentration of C6. Dose–response curve was fit
with Hill equation in Origin 8.0.
Perforated patch clamp was performed with nystatin (Sigma) at 150 μg/mL
in the pipette solution. After seal formation, the RMP of cells expressing
hHv1 channels was measured in current-clamp configuration after attain-
ment of whole-cell configuration with 10 mM Hepes, 136 mM KCl, 1 mM
MgCl2, 2 mM K2ATP, 5 mM EGTA, pH 7.2 in the pipette and the bath solution
described in Two-Color smTIRF for Photobleaching and Analysis of Fluores-
cence Colocalization and hHv1 Subunit Stoichiometry.
Xenopus laevis oocytes were injected with cRNA encoding hKv2.1 or
hS3-S4Kv2.1. Recording solution was as follows (in mM): 50 KCl, 50 NaCl,
1 MgCl2, 0.3 CaCl2, 10 Hepes, pH 7.5, with 0.05% BSA (fraction V; Fisher
Scientific). Recordings were performed with constant gravity flow of solution
at 2 mL/min yielding chamber exchange in ∼5 s. Currents were recorded 1–3 d
after cRNA injection using an Oocyte clamp amplifier OC-725C (Warner In-
struments), and electrodes were filled with 3M KCl with resistance of 0.3–1MΩ.
Data were filtered at 1 kHz and digitized at 20 kHz using pClamp software and
assessed with Clampfit v9.0 and Origin 8.0.
Sperm Electrophysiology and Membrane Potential Measurements. Procedures
were approved by the Bioethics Committee at the Biotechnology Institute
from the National Autonomous University of Mexico. All semen donors gave
written informed consent. Ejaculates were obtained from healthy donors by
masturbation after at least 48 h of sexual abstinence. Only semen samples
that fulfilled the World Health Organization 2010 guidelines were selected
for experiments. Motile spermwere recovered after a swim-up separation for
1 h in modified Krebs–Ringer bicarbonate medium under noncapacitation
conditions (without BSA and Ca2+) at 37 °C in a humidified atmosphere of
5% CO2–95% air. Spermatozoa were stored in physiological solution com-
prising the following (in mM): 135 NaCl, 5 KCl, 1 MgSO4, 2 CaCl2, 5 glucose,
1 sodium pyruvate, 10 lactose, and 20 Hepes (pH 7.4) until used in electro-
physiological recordings.
Whole-cell patch clamp was used for recording proton currents sealing at
the cytoplasmic droplet from mature human spermatozoa plated on poly-
lysine–coated coverslips. Pipettes (20–30 MΩ) were filled with the following:
135 mM N-methyl-D-glucamine (NMDG), 5 mM ethylene glycol tetraacetic
acid (EGTA), and 100 mMMes (pH 6.0) with methanesulfonic acid (CH3SO3H).
Seals between the patch pipette and the sperm cytoplasmic droplet were
formed in physiological solution. After transition into whole-cell mode, the
bath solution was changed for proton current recording (in mM): 130 NMDG,
1 EDTA, and 100 Hepes (pH 7.4) with CH3SO3H. Pulse protocol application
and data acquisition were performed with a patch-clamp amplifier (Axopatch
200; Molecular Devices) and using the pCLAMP6 software (Molecular Devices).
Data were sampled at 2–5 kHz and filtered at 1 kHz and were analyzed with
Clampfit 10.6 (Molecular Devices) and SigmaPlot 9.0 (Systat Software). Data
were calculated and plotted as the mean ± SEM, and n = 4. All electrophysi-
ological recordings were performed at 23 °C.
Mature spermwere collected and diluted in noncapacitating medium, and
exposed to 1 μM Dis-C3-(5). After adding 3.5 mM EGTA, which chelates ex-
ternal Ca2+ and allows Na+ to pass through Catsper channels, fluorescence
(620/670 nm excitation/emission) was recorded continuously, as previously
described (50). Calibration was performed by supplementing with 1 μM
valinomycin and with sequential additions of KCl.
Sperm Physiology and Biochemistry. Human semen samples were provided by
masturbation from healthy volunteer donors. The informed consent signed
by the donors and the protocol for semen sample handling were approved by
the Ethics Committee of the School of Medicine, National University of Cuyo.
After sample liquefaction (20–30 min at 37 °C), highly motile sperm were
recovered by swim-up separation for 1 h in human tubal fluid media (HTF)
(as formulated by Irvine Scientific) supplemented with 5 mg/mL BSA at 37 °C
in an atmosphere of 5% CO2/95% air. Sperm suspensions were diluted to
107 sperm/mL with HTF-BSA and incubated 3–4 h in the presence or ab-
sence of peptides under conditions that promote capacitation. After this
incubation, sperm physiology was assessed by different assays.
Acrosome reaction. Sperm were incubated for 30 min at 37 °C with 15 μM
progesterone, spotted on slides, air-dried, and stained with FITC-coupled
Pisum sativum agglutinin (FITC-PSA) (25 μg/mL in PBS) for 40 min at room
temperature. For some experiments, before stimulation with progesterone,
sperm were first capacitated and then incubated for 30 min with the pep-
tides. The presence of an intact acrosome was assessed in at least 200 cells
per condition using an upright Nikon Optiphot II microscope equipped with
epifluorescence optics. Acrosome reaction was expressed as a percentage of
the stimulation observed in sperm incubated in the absence of toxins
(control, 100%).
Tyrosine phosphorylation. Sperm were lysed and proteins were separated on
Tris-tricine-SDS gels and transferred to 0.45-μm nitrocellulose membranes
(Hybond; GE Healthcare). Nonspecific reactivity was blocked by incubation
for 1 h at room temperature with 5% (wt/vol) BSA dissolved in washing
buffer (PBS with 0.2% Tween 20, pH 7.6). Blots were incubated with the anti-
phosphotyrosine, or anti–α-tubulin antibodies in blocking solution for 1 h at
room temperature. HRP-conjugated goat anti-mouse IgGs were used as
secondary antibodies with 1-h incubations. Excess of first and second anti-
bodies was removed by washing five times for 10 min each in washing
buffer. Detection was performed with a Millipore chemiluminescence system
and a Fujifilm LAS-4000 Luminescent Image Analyzer. Quantification of
signal intensities was performed with ImageJ software.
Viability and motility measurements. Capacitated sperm were observed in bright
field using a Nikon TE300 microscope. One-minute videos were obtained and
analyzed with ImageJ software and CASA plugin for measuring motility
parameters.
Intracellular Ca2+ measurements. Sperm were incubated with 2 μM Fluo-3 AM
(Invitrogen) in the dark at 37 °C during 30 min. Cells were washed once with
human sperm medium (HSM) with the following (in mM): 120 NaCl, 4 KCl,
2 CaCl2, 15 NaHCO3, 1 MgCl2, 10 Hepes, 5 D-glucose, 1 sodium pyruvate, and
10 L-(+)-lactate acid adjusted to pH 7.4 and placed in 300-μL cuvette with
continuous stirring. Fluorescence intensity was measured with an Aminco
Bowman II spectrofluorimeter (λEx = 506, λEm = 526). Data were collected
during 350 s at a frequency of 0.5 Hz. The raw intensity values were nor-
malized as [(F/Fo)−1], where F is fluorescence intensity at time t and Fo is the
mean of F taken during the control period. The resulting values were
expressed as relative fluorescence (RF) normalized to the maximum fluo-
rescence obtained after the TX-100 addition. Statistical analyses were per-
formed using Tukey’s multiple-comparison posttest. Results were considered
significantly different at P < 0.05.
ROS Assay. Single-donor human whole blood was purchased from Innovative
Research. The protocol for blood sample handling was approved by the In-
stitutional Biosafety Committee at Brandeis University. Bloodwas usedwithin
48 h of sampling and stored at 4 °C with K2 EDTA as an anticoagulant until
use. Upon arrival, cells were counted and diluted to 5 × 106 cells per mL in
Tyrode’s solution (TS) (Sigma). A volume of 180 μL of a buffer solution
containing 100 μM Amplex Red (Life Technologies) and 0.5 units/mL HRP in
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TS was added to each well in a 96-well plate. Diluted blood (20 μL) was
added to each well. ZnCl2 (100 μM), KTx* (10 μM), or various concentrations
of C6 were added to selected wells in triplicate. Plates were incubated at
37 °C for 1 h. PMA (200 nM) (Sigma) was added to selected wells, and
fluorescence was recorded immediately at 530/590 nm (excitation/emission).
Fluorescence was recorded every 10 min for 1 h after PMA addition.
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